GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » EBIT per Share

Sinopharm Tech Holdings (HKSE:08156) EBIT per Share : HK$-0.00 (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings EBIT per Share?

Sinopharm Tech Holdings's EBIT per Share for the three months ended in Dec. 2024 was HK$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 39.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 24.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sinopharm Tech Holdings's EBIT per Share or its related term are showing as below:

HKSE:08156' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -41.9   Med: 26   Max: 62.5
Current: 39.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sinopharm Tech Holdings was 62.50% per year. The lowest was -41.90% per year. And the median was 26.00% per year.

HKSE:08156's 3-Year EBIT Growth Rate is ranked better than
82.61% of 2047 companies
in the Software industry
Industry Median: 11.2 vs HKSE:08156: 39.90

Sinopharm Tech Holdings's EBIT for the three months ended in Dec. 2024 was HK$0.00 Mil.


Sinopharm Tech Holdings EBIT per Share Historical Data

The historical data trend for Sinopharm Tech Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings EBIT per Share Chart

Sinopharm Tech Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.89 -0.56 -0.43 -0.01 0.02

Sinopharm Tech Holdings Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 - - - -

Sinopharm Tech Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sinopharm Tech Holdings's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

EBIT per Share(A: Jun. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=3.601/183.693
=0.02

Sinopharm Tech Holdings's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

EBIT per Share(Q: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=0/298.639
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings  (HKSE:08156) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Sinopharm Tech Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Chiu Sin Nang Kenny 2201 Interest of corporation controlled by you
Creative Big Limited 2101 Beneficial owner
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited 2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines